PACAP-38 and sex hormones in women with migraine: exploratory analysis of a cross-sectional, matched cohort study.
J Headache Pain
; 25(1): 98, 2024 Jun 11.
Article
em En
| MEDLINE
| ID: mdl-38858641
ABSTRACT
BACKGROUND:
Endogeneous and exogeneous sex hormones can impact the frequency and severity of migraine attacks, but the underlying mechanisms are poorly understood. In this study, we investigate the relationship between female sex hormones and Pituitary Adenylate Cyclase-Activating Polypeptide-38 (PACAP-38) concentrations in plasma of women with migraine and healthy controls, aiming to elucidate potential hormonal influences on PACAP dynamics and their relevance to migraine pathophysiology.METHODS:
This analysis is part of a cross-sectional, matched-cohort study. We recruited two groups of women with episodic migraine one with a regular menstrual cycle (M-RMC) and another undergoing combined oral contraceptive treatment (M-COC). Additionally, we included corresponding age-matched control groups without migraine for both categories (C-RMC and C-COC). For participants with a RMC, the study visits were scheduled during the perimenstrual period (menstrual cycle day 2 ± 2) and periovulatory period (day 13 ± 2). Participants using COC were examined at day 4 ± 2 of the hormone-free interval and between day 7-14 of the hormone intake phase. During these visits, PACAP-38 concentrations in plasma were measured using a commercial Enzyme-linked-immunosorbent assay (ELISA) kit.RESULTS:
The study included 120 women, with 30 participants in each group. Women with migraine and a RMC had significantly higher PACAP-38 plasma concentrations compared to healthy controls at both study visits [day 2 ± 2 M-RMC 2547.41 pg/ml (IQR 814.27 - 4473.48) vs. C-RMC 1129.49 pg/ml (IQR 257.34 - 2684.88), p = 0.025; day 13 ± 2 M-RMC 3098.89 pg/ml (IQR 1186.29 - 4379.47) vs. C-RMC 1626.89 (IQR 383.83 - 3038.36), p = 0.028]. In contrast, PACAP-38 levels were comparable between migraine and control groups receiving COC. Women with migraine and a RMC exhibited higher PACAP-38 concentrations during menstruation compared to those using COC during the hormone-free interval.CONCLUSION:
Systemic PACAP-38 concentrations in women vary based on the presence of migraine diagnosis and their hormonal status.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Polipeptídeo Hipofisário Ativador de Adenilato Ciclase
/
Transtornos de Enxaqueca
Limite:
Adult
/
Female
/
Humans
Idioma:
En
Revista:
J Headache Pain
Assunto da revista:
MEDICINA INTERNA
/
NEUROLOGIA
/
PSICOFISIOLOGIA
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Alemanha